Refine by
Blood Disease Articles & Analysis
64 news found
This innovative platform is specifically designed to overcome the primary challenge in treating brain diseases: the blood-brain barrier (BBB). By leveraging a suite of biomimetic and AI-powered technologies, BBBporter™ enables the efficient transport of therapeutic candidates into the brain, opening new avenues for preclinical drug development in areas such ...
This new product line offers researchers a powerful tool to study a wide range of diseases affecting the heart, blood vessels, and spleen. CD BioSciences is committed to providing researchers with a comprehensive range of reliable imaging products and analysis services that enable them to make significant contributions to biomedical research. ...
In recent years, CRISPR technology has significantly promoted the innovation of gene therapy for blood diseases, tumors, genetic diseases, and other diseases, which has become a powerful tool in the field of scientific research. ...
DESCRIPTION provided by applicant Heart disease is the leading cause of death for both men and women in the US accounting for nearly of all annual deaths A high cholesterol level is well known risk factors for heart disease Although blood cholesterol can be lowered using a number of marketed drugs of which statins are the leading drugs only of ...
A high cholesterol level is a well-known risk factors for heart disease. Although blood cholesterol can be lowered using a number of marketed drugs, of which statins are the leading drugs, only 38% of patients taking these drugs are achieving the low-density lipoprotein cholesterol goals set by the National Cholesterol Education Program (NCEP). ...
Exclusive global license for CORE NK platform (CHM 0201) executed with Case Western Reserve University in Ohio Initial Phase 1 clinical trial results of the CORE NK platform (CHM 0201) were published demonstrating safety and encouraging activity in blood cancers and solid tumours One patient achieved a complete response that was sustained for over 15 months at time of ...
An estimated 415 million people are living with diabetes in the world. Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as ...
Creatinine Assay Kit Altered creatinine levels can be an indicator of kidney dysfunction or other medical conditions that result in lower renal blood flow such as diabetes or cardiovascular disease. Creative Enzymes provides high-quality creatinase (EC 3.5.3.3), creatininase (EC 3.5.2.10), and sarcosine oxidase (EC 1.5.3.1), which are raw materials used in the ...
Various scars, including trauma scars, burn scars, suture scars, pigmentation, ichthyosis, goose skin disease, red blood, etc. Pigmented lesions, including freckles, sunburn, etc. ...
In the future, we will leverage Fosun Pharma’s advantages in the fields of kidney and blood system diseases and other therapeutic fields to improve the availability of medicines for patients and benefit more Chinese ...
CO2 fractional laser treatment process and precautions Indications: ▶Various scars: trauma scars, burn scars, suture scars, stains, ichthyosis, goose skin disease, red blood, etc. ▶Various wrinkles and scars: acne, facial and forehead wrinkles, joint wrinkles, stretch marks, eyelids, crow's feet and other fine lines around the eyes, dry lines, etc. ▶ Pigmented ...
” Individuals with refractory angina experience pressure or intense pain in the chest due to insufficient blood flow to the heart muscle. These symptoms can severely impact quality of life and may worsen comorbidities. ...
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research Reports Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today ...
A Phase 1b clinical trial (NCT04995653) is now enrolling adults undergoing allogeneic HSCT to test whether the investigational microbiome therapeutic SER-155 is safe and effective at preventing graft-versus-host disease, blood infections and other serious complications. The trial is designed to enroll 10 participants in an initial open-label cohort to gauge ...
Additionally, a symposium titled, “Cellular senescence and immune response in ocular health and disease,” featured leading researchers in the field who discussed the role of cellular senescence and aging in various eye diseases, as well as promising therapeutic approaches to target this pathway. As demonstrated in preclinical studies, Bcl-xL is highly ...
April 25, 2022 at 9:30 AM EDT NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Apr. 25, 2022-- Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the patent regarding ...
Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today announced the publication of a study in the journal npj Precision Oncology that describes the discovery and validation of miRisk, a first-of-its-kind microRNA (miRNA) biomarker signature that offers the prospect of a ...
“There is a high burden of type 2 diabetes in Japan, and a large proportion of people with type 2 diabetes develop chronic kidney disease. Despite well-controlled blood glucose levels and blood pressure, patients with chronic kidney disease and type 2 diabetes remain at risk of chronic kidney disease ...
ByBayer AG
“Given the accelerating global epidemic of T2D, new approaches are desperately needed in order to reduce disease burden, improve outcomes, and increase value. Despite the availability of a wide variety of therapeutic options, T2D remains a progressive, expensive, debilitating disease. ...
“We are committed to rigorously evaluating the safety and effectiveness of Revita in patients with T2D across the spectrum of disease with our Revitalize T2D clinical development program.” About Revita® Fractyl Health’s lead product candidate, Revita, is based on the company’s insights surrounding the potential role of the gut in metabolic ...